Impact of progesterone on cytokine-stimulated nuclear factor-kappaB signaling in HeLa cells

J Matern Fetal Neonatal Med. 2007 Jan;20(1):23-8. doi: 10.1080/14767050601128019.

Abstract

Objective: A key event in the pathways leading to preterm labor may be the activation of nuclear factor-kappaB (NF-kappaB) in the fetal membranes and the cervix. Anti-inflammatory agents, such as the corticosteroids, inhibit the activation of NF-kappaB. We proposed to investigate the effects of progesterone pretreatment on cytokine-stimulated activation of NF-kappaB in HeLa cells, a human cervical epithelial cell line.

Methods: HeLa cells were pretreated with 10(-7) M progesterone for 24 hours and exposed to 1 ng/mL interleukin-1beta (IL-1beta) for 1 hour. Nuclear and cytosolic extracts were subjected to Western blot analysis using anti-p65 and anti-inhibitory protein-kappaBalpha (anti-IkappaBalpha) antibodies. Densitometric data (n=5) were compared using Kruskal-Wallis test.

Results: Pretreatment with progesterone interfered with IL-1beta-induced IkappaBalpha degradation. However, progesterone pretreatment resulted in a significant decrease in NF-kappaB protein subunit p65 in the cytoplasm. Pretreatment with progesterone did not reduce the amount of nuclear p65 and did not interfere with nuclear translocation of p65.

Conclusion: Our observations suggest that any possible role played by progesterone in preterm labor prevention is not exerted through anti-inflammatory mechanisms of NF-kappaB down-regulation.

MeSH terms

  • HeLa Cells
  • Humans
  • Interleukin-1beta / pharmacology
  • NF-kappa B / drug effects*
  • NF-kappa B / metabolism
  • Premature Birth / metabolism
  • Progesterone / pharmacology*
  • Progestins / pharmacology*
  • Signal Transduction / drug effects*
  • Transcription Factor RelA / drug effects
  • Transcription Factor RelA / metabolism

Substances

  • Interleukin-1beta
  • NF-kappa B
  • Progestins
  • Transcription Factor RelA
  • Progesterone